Penserra Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2K Hold
12
﹤0.01% 1017
2025
Q4
$2K Hold
12
﹤0.01% 991
2025
Q3
$3K Sell
12
-780
-98% -$213K ﹤0.01% 929
2025
Q2
$204K Buy
792
+780
+6,500% +$186K ﹤0.01% 653
2025
Q1
$2K Sell
12
-372
-97% -$86.8K ﹤0.01% 989
2024
Q4
$87K Buy
384
+372
+3,100% +$89.6K ﹤0.01% 876
2024
Q3
$2K Hold
12
﹤0.01% 1031
2024
Q2
$2K Hold
12
﹤0.01% 1177
2024
Q1
$2K Sell
12
-669
-98% -$123K ﹤0.01% 1157
2023
Q4
$117K Sell
681
-142
-17% -$21.8K ﹤0.01% 876
2023
Q3
$120K Sell
823
-131
-14% -$23.7K ﹤0.01% 856
2023
Q2
$207K Buy
954
+946
+11,825% +$211K ﹤0.01% 780
2023
Q1
$1K Hold
8
﹤0.01% 1073
2022
Q4
$1K Buy
+8
New +$1.76K ﹤0.01% 1114
2020
Q4
Sell
-468
Closed -$80K 1118
2020
Q3
$80K Sell
468
-34,430
-99% -$6.36M ﹤0.01% 540
2020
Q2
$6.7M Buy
34,898
+34,283
+5,574% +$5.61M 0.35% 97
2020
Q1
$100K Sell
615
-3,629
-86% -$578K 0.01% 575
2019
Q4
$692K Buy
4,244
+3,672
+642% +$529K 0.04% 319
2019
Q3
$77K Buy
572
+173
+43% +$22.7K 0.01% 594
2019
Q2
$48K Buy
399
+33
+9% +$3.65K ﹤0.01% 592
2019
Q1
$38K Sell
366
-14,563
-98% -$1.5M ﹤0.01% 574
2018
Q4
$1.7M Buy
+14,929
New +$1.6M 0.17% 102

Other funds holding RMD

Penserra Capital Management's RMD Position: Q1 2026 in Review

Penserra Capital Management held its ResMed (RMD) position steady in Q1 2026 at 12 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

Penserra Capital Management first reported a position in RMD in Q4 2018 and has held it in 22 quarters since. The position peaked at $6.7M in Q2 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Penserra Capital Management held 12 shares of ResMed worth $2K as of Q1 2026.
  • Penserra Capital Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up ﹤0.01% of Penserra Capital Management's portfolio in Q1 2026, its #1017 holding.
  • Penserra Capital Management first reported a position in ResMed in Q4 2018 and has held it in 22 quarters since.
  • Penserra Capital Management's ResMed position peaked at $6.7M in Q2 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Penserra Capital Management's 13F filing for Q1 2026, filed 11 May 2026.